Summary:
The study is for individuals with Alzheimer's Disease or mild cognitive impairment due to Alzheimer's Disease. The study lasts 18 months with an optional 24 month long-term extension. The study includes the completion of MRI and PET scan imaging.
Qualified Participants Must:
Be between 50 and 95 years of age
Have experienced memory decline for at least one year
Qualified Participants May Receive:
Study-related medical care and study medication; reimbursement for time and travel will be provided